Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gallbladder dyskinesia.

Stephanie L Hansel1, John K Dibaise

  • 1John K. DiBaise, MD Division of Gastroenterology and Hepatology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. dibaise.john@mayo.edu.

Current Treatment Options in Gastroenterology
|March 7, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designing Integrated Virtual Care Partnerships: Insights from a Practice-Based Case Series at Mayo Clinic.

Mayo Clinic proceedings. Digital health·2026
Same author

Fear, Feeding, and the Gut: Nutrition Support Considerations in Adults with ARFID and Gastrointestinal Symptoms.

Nutrients·2026
Same author

Short bowel syndrome-associated intestinal failure: diagnosis and prognosis.

Expert review of gastroenterology & hepatology·2026
Same author

Discordance between MR enterography and endoscopic detection of Crohn's disease ileal strictures: evidence to inform recommendations.

Abdominal radiology (New York)·2024
Same author

Gut instinct: Navigating the landscape of parenteral support in short bowel syndrome.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2024
Same author

Relationship Functioning and Gut Microbiota Composition among Older Adult Couples.

International journal of environmental research and public health·2023
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Diagnosing gallbladder dyskinesia is challenging. While cholecystokinin-cholescintigraphy (CCK-CS) may aid diagnosis, high clinical suspicion and conservative management are often recommended pending further research.

Area of Science:

  • Gastroenterology
  • Hepatobiliary Medicine
  • Diagnostic Imaging

Background:

  • Gallbladder dyskinesia diagnosis and management remain debated.
  • Identifying characteristic biliary pain features is difficult.
  • Current literature lacks consensus on symptom reliability for predicting post-cholecystectomy pain relief.

Purpose of the Study:

  • To review the diagnostic and management strategies for suspected gallbladder dyskinesia.
  • To evaluate the utility of cholecystokinin-cholescintigraphy (CCK-CS) in predicting outcomes.
  • To highlight the need for further research in this clinically challenging condition.

Main Methods:

  • Review of existing literature on gallbladder dyskinesia diagnosis and management.
  • Discussion of cholecystokinin-cholescintigraphy (CCK-CS) and its role.

Related Experiment Videos

  • Analysis of clinical experience and patient selection criteria.

    • Main Results:

    • No definitive recommendation for CCK-CS due to lack of quality evidence.
    • CCK-CS may be beneficial in select patients with slow CCK infusion.
    • Clinical suspicion, conservative management, and patient counseling are currently suggested.

    Conclusions:

    • Further large-scale, prospective, controlled studies are essential.
    • Standardized CCK-CS methods and outcome measures are needed.
    • Understanding pathophysiology and optimizing management require robust research.